Global burden of gallbladder cancer in 2022 and predictions to 2042
Digestive and Liver Disease · 2025-06 · 57 (6) · 1294-1300
DOI: 10.1016/j.dld.2025.02.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025-06. Verfasst von Hanfeng Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha 410013, Hunan Province, China; Hunan Key Laboratory …. Hauptthemen laut MEDLINE: Gallbladder Neoplasms, Global Health. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha 410013, Hunan Province, China; Hunan Key Laboratory of Nonresolving Inflammation and Cancer, Changsha 410013, Hunan Provin…
Förderung
- National Natural Science Foundation of China
- Hunan Provincial Natural Science Foundation
Zitieren
APA
Guo, H., Zhang, D., Li, Z., Liu, S., & Wang, R. (2025). Global burden of gallbladder cancer in 2022 and predictions to 2042. Digestive and Liver Disease, 57(6), 1294-1300. https://doi.org/10.1016/j.dld.2025.02.007
Vancouver
Guo H, Zhang D, Li Z, Liu S, Wang R. Global burden of gallbladder cancer in 2022 and predictions to 2042. Digestive and Liver Disease. 2025;57(6):1294-1300. doi:10.1016/j.dld.2025.02.007
BibTeX
@article{Guo2025,
author = {Guo, Hanfeng and Zhang, Decai and Li, Zhaoqi and Liu, Shaojun and Wang, Rui},
title = {Global burden of gallbladder cancer in 2022 and predictions to 2042},
journal = {Digestive and Liver Disease},
year = {2025},
volume = {57},
number = {6},
pages = {1294--1300},
doi = {10.1016/j.dld.2025.02.007}
}
EUVIMED